Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309314 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Mathias Mlewa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Mwanza University, Mwanza, Tanzania. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Antiviral Agents. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chronic hepatitis B virus (HBV) infection is still a major public health problem. In response to the World Health Organization (WHO), Tanzania implemented immunization and treatment to achieve the eradication of HBV infection by 2030. To achieve this goal, frequent updates of demographic data, antiviral therapy eligibility, and uptake are essential. We therefore evaluated demographic data, antiviral therapy eligibility, and uptake among chronically HBV-infected patients attending at Bugando Medical Centre (BMC), Tanzania.
Methods
A cross-sectional study enrolled 196 chronic HBV patients from April 23, 2023, to October 10, 2023, at BMC, where 100 and 96 patients were retrospectively and prospectively enrolled, respectively. Study’s ethical clearance and permission were observed by the Catholic University of Health and Allied Sciences/Bugando Medical Centre research ethics and review committee and the Bugando Medical Centre management respectively. For all patients, socio-demographic data and whole blood samples were obtained. Full blood picture, alanine and aspartate amino transferases, and HBV viral load parameters were determined. Aspartate-Platelet Ratio Index (APRI) and Fibrosis Four (FIB-4) scores were calculated according to their respective formulas. Therapy eligibility and uptake were evaluated according to the 2015 WHO HBV prevention, treatment, and care guidelines. The data were summarized and analysed using STATA version 15.
Results
The median age for all patients was 39 [IQR: 32–47.5] years. Nearly all study patients, 99% (194/196), were older than 20 years old, with significant male dominance (73.5% [144/196] versus 26.5% [52/196]; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Mwanza University, Mwanza, Tanzania.
- Department of Microbiology and Immunology, Catholic University of Health, and Allied Sciences, Mwanza, Tanzania.
- Department of Central Pathology Laboratory, Molecular Biology Laboratory, Bugando Medical Centre, Mwanza, Tanzania.
- Department of Biochemistry and Molecular biology, Mwanza University, Mwanza, Tanzania.
- Department of Public Health, Mwanza University, Mwanza, Tanzania.
- Department of Biochemistry and Molecular Biology, Catholic University of Health, and Allied Sciences, Mwanza, Tanzania.
ORCID-Profile: Mathias Mlewa, Shimba Henerico, Hyasinta Jaka
Zitieren
APA
Mlewa, M., Nyawale, H. A., Henerico, S., Mangowi, I., Shangali, A. R., Manisha, A. M., Kisanga, F., Kidenya, B. R., Jaka, H., Kilonzo, S. B., Mirambo, M. M., & Mshana, S. E. (2024). Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania. PLOS ONE. https://doi.org/10.1371/journal.pone.0309314
Vancouver
Mlewa M, Nyawale HA, Henerico S, Mangowi I, Shangali AR, Manisha AM, et al. Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania. PLOS ONE. 2024. doi:10.1371/journal.pone.0309314
BibTeX
@article{Mlewa2024,
author = {Mlewa, Mathias and Nyawale, Helmut A and Henerico, Shimba and Mangowi, Ivon and Shangali, Aminiel Robert and Manisha, Anselmo Mathias and Kisanga, Felix and Kidenya, Benson R and Jaka, Hyasinta and Kilonzo, Semvua B and Mirambo, Mariam M and Mshana, Stephen E},
title = {Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309314}
}
EUVIMED